SARA KING: Open Payments
NPI 1841603305 · JESUP, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$454 in 25 payments from 10 companies in 2025. Trend: 2023 $337 · 2024 $442 · 2025 $454
Food & beverage: $454
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $116 |
| ABBVIE INC. | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $67 |
| E.R. Squibb & Sons, L.L.C. | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $37 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
| Corium, LLC | 1 | $17 |
| Tris Pharma Inc | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: REXULTI, VRAYLAR, CAPLYTA, COBENFY, Jornay PM, ARISTADA, INGREZZA, Azstarys.
Industry payments across IA — which companies pay providers there.
